• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人家族性地中海热的季节性残留活性:一项纵向观察性研究。

Seasonal residual activity in adult familial Mediterranean fever: a longitudinal observational study.

机构信息

Kartal Dr. Lutfi Kirdar City Hospital, Rheumatology Clinic, Istanbul, Turkey.

Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey.

出版信息

Rheumatol Int. 2022 Sep;42(9):1573-1578. doi: 10.1007/s00296-022-05156-7. Epub 2022 Jun 8.

DOI:10.1007/s00296-022-05156-7
PMID:35676438
Abstract

Although it is assumed that cold exposure triggers inflammation in patients with familial Mediterranean fever (FMF), seasonal differences in FMF have not yet been investigated. This study aims to investigate the association of seasonal changes with the frequency of attacks, disease severity, and subclinical inflammation in FMF. This longitudinal study examined adult patients with FMF on an established treatment followed up for at least 1 year in Istanbul. Clinical characteristics, medications, intraseasonal attacks counts, arthralgia and arthritis, disease severity, and the subclinical inflammation parameters were recorded covering four seasons. Friedman's and Cochran's Q tests were used to analyze changes in the above-mentioned data over seasons. Additionally, all attacks experienced in each season were added, and interseasonal differences were compared with the Chi-square goodness-of-fit test. Data for 240 observations (60 patients) were analyzed. The mean age and disease duration were 39.78 (SD 11.91) and 10 (IQR 6-22.75) years, respectively. The comparison of medians for four seasons did not show any statistical differences in terms of attack frequency, disease severity parameters, markers of subclinical inflammation, and the presence of arthralgia and arthritis. The total number of intraseasonal attacks experienced by patients differed among the seasons (p = 0.023), with a higher count in winter. Adult individuals with established FMF are more likely to experience attacks in winter than summer, but this difference may not be seen in the general parameters of disease activity/severity. This result supports the notion that there is a pronounced residual activity in winter.

摘要

尽管人们认为寒冷暴露会引发家族性地中海热(FMF)患者的炎症,但 FMF 的季节性差异尚未得到研究。本研究旨在调查季节性变化与 FMF 发作频率、疾病严重程度和亚临床炎症之间的关联。这项纵向研究在伊斯坦布尔对接受既定治疗的成年 FMF 患者进行了检查,这些患者的随访时间至少为 1 年。临床特征、药物、季节内发作次数、关节痛和关节炎、疾病严重程度和亚临床炎症参数在四个季节中均有记录。使用 Friedman 和 Cochran Q 检验分析了上述数据随季节的变化。此外,还对每个季节经历的所有攻击进行了加总,并使用卡方拟合优度检验比较了季节间的差异。对 240 次观察(60 例患者)的数据进行了分析。平均年龄和疾病持续时间分别为 39.78(SD 11.91)岁和 10(IQR 6-22.75)年。四个季节中位数的比较显示,在发作频率、疾病严重程度参数、亚临床炎症标志物以及关节痛和关节炎的存在方面,均无统计学差异。患者在季节间经历的季节内发作总数存在差异(p=0.023),冬季发作次数更高。患有既定 FMF 的成年人在冬季比夏季更有可能发作,但这种差异在疾病活动/严重程度的一般参数中可能不会出现。这一结果支持了冬季仍有明显残留活动的观点。

相似文献

1
Seasonal residual activity in adult familial Mediterranean fever: a longitudinal observational study.成人家族性地中海热的季节性残留活性:一项纵向观察性研究。
Rheumatol Int. 2022 Sep;42(9):1573-1578. doi: 10.1007/s00296-022-05156-7. Epub 2022 Jun 8.
2
Interventions for reducing inflammation in familial Mediterranean fever.家族性地中海热的抗炎干预措施。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD010893. doi: 10.1002/14651858.CD010893.pub4.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Interventions for reducing inflammation in familial Mediterranean fever.降低家族性地中海热炎症的干预措施。
Cochrane Database Syst Rev. 2015 Mar 20(3):CD010893. doi: 10.1002/14651858.CD010893.pub2.
5
Characteristics of arthritis in patients with familial Mediterranean fever.家族性地中海热患者关节炎的特征。
Intern Med J. 2024 Nov;54(11):1802-1808. doi: 10.1111/imj.16495. Epub 2024 Aug 21.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review.家族性地中海热治疗的疗效与安全性:一项系统评价
Rheumatol Int. 2016 Mar;36(3):325-31. doi: 10.1007/s00296-015-3408-9. Epub 2015 Dec 19.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
The climate emergency for rheumatologists: where do we stand?风湿病学家面临的气候紧急情况:我们处于什么立场?
Clin Rheumatol. 2025 Feb;44(2):573-582. doi: 10.1007/s10067-024-07284-w. Epub 2024 Dec 22.
2
Factors triggering familial mediterranean fever attacks, do they really exist?触发家族性地中海热发作的因素真的存在吗?
Intern Emerg Med. 2024 Jun;19(4):1007-1013. doi: 10.1007/s11739-024-03576-w. Epub 2024 Mar 15.
3
Do we consider enough the presence of triggering factors in the evaluation of patients with FMF? Triggering factors are highly prevalent in colchicine-resistant FMF patients.

本文引用的文献

1
IL-1 blockers together with colchicine may be administered as first line therapy in familial Mediterranean fever with amyloidosis.IL-1 阻滞剂联合秋水仙碱可作为伴淀粉样变的家族性地中海热的一线治疗药物。
Med Hypotheses. 2019 Sep;130:109269. doi: 10.1016/j.mehy.2019.109269. Epub 2019 Jun 10.
2
Influence of seasonal changes on disease activity and distribution of affected joints in rheumatoid arthritis.季节性变化对类风湿关节炎疾病活动和受累关节分布的影响。
BMC Musculoskelet Disord. 2019 Jan 18;20(1):30. doi: 10.1186/s12891-019-2418-2.
3
Cold Exposure Related Fever with an Mediterranean Fever (MEFV) Gene Mutation.
我们在评估 FMF 患者时是否充分考虑了触发因素的存在?在对 colchicine 耐药性 FMF 患者的评估中,触发因素非常普遍。
Intern Emerg Med. 2024 Mar;19(2):391-397. doi: 10.1007/s11739-023-03486-3. Epub 2023 Dec 16.
与地中海热(MEFV)基因突变相关的冷暴露性发热
Intern Med. 2017 Aug 15;56(16):2233-2236. doi: 10.2169/internalmedicine.8274-16. Epub 2017 Aug 1.
4
Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity.季节与自身免疫性疾病:四季对自身免疫马赛克的贡献。
J Autoimmun. 2017 Aug;82:13-30. doi: 10.1016/j.jaut.2017.06.001. Epub 2017 Jun 16.
5
Seasonal variations in fatigue in persons with rheumatoid arthritis: a longitudinal study.类风湿关节炎患者疲劳的季节性变化:一项纵向研究。
BMC Musculoskelet Disord. 2016 Feb 4;17:59. doi: 10.1186/s12891-016-0911-4.
6
Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF).国际家族性地中海热严重程度评分系统(ISSF)的制定与初步验证。
Ann Rheum Dis. 2016 Jun;75(6):1051-6. doi: 10.1136/annrheumdis-2015-208671. Epub 2016 Jan 28.
7
EULAR recommendations for the management of familial Mediterranean fever.欧洲抗风湿病联盟家族性地中海热管理建议。
Ann Rheum Dis. 2016 Apr;75(4):644-51. doi: 10.1136/annrheumdis-2015-208690. Epub 2016 Jan 22.
8
Seasonal Variation in Flares of Intestinal Behçet's Disease.肠道白塞病发作的季节性变化
Dig Dis Sci. 2015 Nov;60(11):3373-8. doi: 10.1007/s10620-015-3863-x. Epub 2015 Sep 19.
9
Association between colchicine resistance and vitamin D in familial Mediterranean fever.家族性地中海热中秋水仙碱耐药性与维生素D之间的关联。
Ren Fail. 2015 Aug;37(7):1122-5. doi: 10.3109/0886022X.2015.1056064. Epub 2015 Jun 12.
10
Current trends in colchicine treatment in familial Mediterranean fever.家族性地中海热中秋水仙碱治疗的当前趋势。
Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):41-6. Epub 2013 Sep 9.